Combination lipid-lowering therapy as first-line strategy in very high-risk patients
Kausik K. Ray, Laurens F. Reeskamp, Ulrich Laufs, Maciej Banach, François Mach, Lâle Tokgözoğlu, Derek Connolly, Anja J. Gerrits, Erik S.G. Stroes, L. Masana, John J.P. Kastelein
Abstract
Combination lipid-lowering therapy as first line strategy in very high-risk patients. Combination lipid-lowering therapy as first line strategy in very high-risk patients.
Topics & Concepts
MedicineInternal medicineLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders